Activin, TGF-β and Menin in Pituitary Tumorigenesis

被引:0
|
作者
Lebrun, Jean-Jacques [1 ]
机构
[1] McGill Univ, Royal Victoria Hosp, Dept Med, Hormones & Canc Res Unit, Montreal, PQ H3A 1A1, Canada
基金
加拿大健康研究院;
关键词
GROWTH-FACTOR-BETA; MULTIPLE ENDOCRINE NEOPLASIA; TUMOR-SUPPRESSOR GENE; CELL-GROWTH; EPITHELIAL-CELLS; SMAD PROTEINS; EXPRESSION; MUTATIONS; PROLACTIN; ADENOMAS;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Pituitary adenomas are common monoclonal neoplasms accounting for approximately one-fifth of primary intracranial tumors. Prolactin-secreting pituitary adenomas (prolactinomas) are the most common form of pituitary tumors in humans. They are associated with excessive release of the hormone prolactin and increased tumor growth, giving rise to severe endocrine disorders and serious clinical concerns for the patients. Recent studies indicated that the activin/TGF-beta family of growth factors plays a prominent role in regulating pituitary tumor growth and prolactin secretion from anterior pituitary lactotrope cells. Furthermore, these studies highlighted the tumor suppressor menin and the protein Smads as central regulators of these biological processes in the pituitary. Alterations in the activin/TGF-beta downstream signaling pathways are critical steps towards tumor formation and progression. This chapter will review the role and intracellular molecular mechanisms of action by which activin, TGF-beta, Smads and menin act in concert to prevent pituitary tumor cell growth and control hormonal synthesis by the anterior pituitary.
引用
收藏
页码:69 / 78
页数:10
相关论文
共 50 条
  • [31] During hematopoiesis, expression of FLRG, a novel activin A ligand, is regulated by TGF-β
    Maguer-Satta, V
    Bartholin, L
    Jeanpierre, S
    Gadoux, M
    Bertrand, S
    Martel, S
    Magaud, JP
    Rimokh, R
    EXPERIMENTAL HEMATOLOGY, 2001, 29 (03) : 301 - 308
  • [32] TGF-β1 and Activin A contribute to inflammation and remodelling in sinusitis and nasal polyps
    Chaker, A.
    Wagenmann, M.
    Bas, M.
    Scheckenbach, K.
    Akdis, C.
    Schmidt-Weber, C.
    ALLERGY, 2007, 62 : 52 - 52
  • [33] The structural basis of TGF-β, bone morphogenetic protein, and activin ligand binding
    Lin, S. Jack
    Lerch, Thomas F.
    Cook, Robert W.
    Jardetzky, Theodore S.
    Woodruff, Teresa K.
    REPRODUCTION, 2006, 132 (02) : 179 - 190
  • [34] TGF-β1 Signalling, Connecting Aberrant Inflammation and Colorectal Tumorigenesis
    Skeen, Victoria R.
    Paterson, Ian
    Paraskeva, Christos
    Williams, Ann C.
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (26) : 3874 - 3888
  • [35] Regulation of brown adipogenesis by the Tgf-β family: Involvement of Srebp1c in Tgf-β- and Activin-induced inhibition of adipogenesis
    Yoshida, Hirofumi
    Kanamori, Yohei
    Asano, Hiroki
    Hashimoto, Osamu
    Murakami, Masaru
    Kawada, Teruo
    Matsui, Tohru
    Funaba, Masayuki
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2013, 1830 (11): : 5027 - 5035
  • [36] Pituitary actions of ligands of the TGF-β family:: activins and inhibins
    Bilezikjian, Louise M.
    Blount, Amy L.
    Donaldson, Cindy J.
    Vale, Wylie W.
    REPRODUCTION, 2006, 132 (02) : 207 - 215
  • [37] TGF-β/activin/nodal signal regulates the fate of human embryonic stem cells
    Wu, Zhao
    Zhang, Wei
    Xiao, Lei
    CELL RESEARCH, 2008, 18 (Suppl 1) : S30 - S30
  • [38] TGF-β/activin/nodal signal regulates the fate of human embryonic stem cells
    Zhao Wu
    Wei Zhang
    Lei Xiao
    Cell Research, 2008, 18 : S30 - S30
  • [39] Interplay between LncRNA/miRNA and TGF-β Signaling in the Tumorigenesis of Gynecological Cancer
    Safavi, Pegah
    Moghadam, Kimia Behrouz
    Haghighi, Zahra
    Ferns, Gordon A.
    Rahmani, Farzad
    CURRENT PHARMACEUTICAL DESIGN, 2024, 30 (05) : 352 - 361
  • [40] TGF-β signaling alters the pattern of liver tumorigenesis induced by Pten inactivation
    Morris, S. M.
    Carter, K. T.
    Baek, J. Y.
    Koszarek, A.
    Yeh, M. M.
    Knoblaugh, S. E.
    Grady, W. M.
    ONCOGENE, 2015, 34 (25) : 3273 - 3282